Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.
Abdelhady, E. (2015). Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.. EKB Journal Management System, 2(2), 1-8. doi: 10.21608/ejhbmt.2015.19702
Emad A Abdelhady. "Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.". EKB Journal Management System, 2, 2, 2015, 1-8. doi: 10.21608/ejhbmt.2015.19702
Abdelhady, E. (2015). 'Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.', EKB Journal Management System, 2(2), pp. 1-8. doi: 10.21608/ejhbmt.2015.19702
Abdelhady, E. Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.. EKB Journal Management System, 2015; 2(2): 1-8. doi: 10.21608/ejhbmt.2015.19702

Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.

Egyptian Journal of Hematology and Bone Marrow Transplantation
Reviewers, Volume 2, Issue 2, 2015, Pages 1-8    PDF (473.43 K)
DOI: 10.21608/ejhbmt.2015.19702
Author
Emad A Abdelhady*
Department of Internal Medicine, Clinical Hematology and Bone Marrow Transplantation Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Statistics
Article View: 197
PDF Download: 286